MX2023010947A - Compuestos antibacterianos. - Google Patents

Compuestos antibacterianos.

Info

Publication number
MX2023010947A
MX2023010947A MX2023010947A MX2023010947A MX2023010947A MX 2023010947 A MX2023010947 A MX 2023010947A MX 2023010947 A MX2023010947 A MX 2023010947A MX 2023010947 A MX2023010947 A MX 2023010947A MX 2023010947 A MX2023010947 A MX 2023010947A
Authority
MX
Mexico
Prior art keywords
antibacterial compounds
compounds
antibacterial
tuberculosis
medicaments
Prior art date
Application number
MX2023010947A
Other languages
English (en)
Inventor
Matthieu Ludovic Jeanty
Jérôme Émile Georges Guillemont
Magali Madeleine Simone Motte
Arilla Maria Cristina Villellas
LAMMENS Godelieve Maria J
Adeline Julie Dominique Marie René
Dirk Antonie Lamprecht
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MX2023010947A publication Critical patent/MX2023010947A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se relaciona con los siguientes compuestos (I), en donde los enteros son como se definen en la descripción, y donde los compuestos pueden ser útiles como medicamentos, por ejemplo, para usar en el tratamiento de la tuberculosis.
MX2023010947A 2021-03-16 2022-03-15 Compuestos antibacterianos. MX2023010947A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21162835 2021-03-16
PCT/EP2022/056588 WO2022194803A1 (en) 2021-03-16 2022-03-15 Antibacterial compounds

Publications (1)

Publication Number Publication Date
MX2023010947A true MX2023010947A (es) 2023-11-29

Family

ID=74884870

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023010947A MX2023010947A (es) 2021-03-16 2022-03-15 Compuestos antibacterianos.

Country Status (10)

Country Link
US (1) US20240199611A1 (es)
EP (1) EP4308239A1 (es)
JP (1) JP2024510478A (es)
KR (1) KR20230157400A (es)
CN (1) CN117396475A (es)
AU (1) AU2022237769A1 (es)
BR (1) BR112023018662A2 (es)
CA (1) CA3211532A1 (es)
MX (1) MX2023010947A (es)
WO (1) WO2022194803A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL222801B1 (pl) 2002-07-25 2016-09-30 Janssen Pharmaceutica Nv Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je
US8865734B2 (en) 2010-03-18 2014-10-21 Institut Pasteur Korea Anti-infective compounds
SG2014014369A (en) 2011-09-01 2014-09-26 Irm Llc Compounds and compositions as c-kit kinase inhibitors
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
KR102178590B1 (ko) 2012-07-18 2020-11-13 유니버시티 오브 노트르 담 듀락 5,5-헤테로방향족 항-감염 화합물
SG11201600686QA (en) 2013-08-02 2016-02-26 Pasteur Institut Korea Anti-infective compounds
CN105524058B (zh) * 2014-10-21 2018-03-27 广州艾格生物科技有限公司 吡唑并[1,5‑a]吡啶类化合物及其应用
MX2017016788A (es) 2015-07-02 2018-07-06 Janssen Sciences Ireland Uc Compuestos antibacterianos.
CA2998375A1 (en) * 2015-09-17 2017-03-23 Marvin J. Miller Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
JP2019518050A (ja) 2016-06-16 2019-06-27 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌薬としての複素環式化合物
EA201990043A1 (ru) 2016-06-16 2019-05-31 Янссен Сайенсиз Айрлэнд Анлимитед Компани Антибактериальные соединения
WO2018084809A1 (en) * 2016-11-02 2018-05-11 Nanyang Technological University Methods for the treatment or prevention of mycobacterial infections
WO2021048342A1 (en) * 2019-09-13 2021-03-18 Janssen Sciences Ireland Unlimited Company Antibacterial compounds

Also Published As

Publication number Publication date
US20240199611A1 (en) 2024-06-20
BR112023018662A2 (pt) 2023-12-19
CN117396475A (zh) 2024-01-12
WO2022194803A1 (en) 2022-09-22
EP4308239A1 (en) 2024-01-24
CA3211532A1 (en) 2022-09-22
AU2022237769A1 (en) 2023-11-02
KR20230157400A (ko) 2023-11-16
JP2024510478A (ja) 2024-03-07

Similar Documents

Publication Publication Date Title
PH12017502297A1 (en) Antibacterial compounds
MX2022003037A (es) Compuestos antibacterianos.
MX2018015656A (es) Compuestos heterociclicos como antibacterianos.
MX2018015657A (es) Compuestos heterociclico como antibacterianos.
MX2023010948A (es) Compuestos antibacterianos.
MX2023010941A (es) Compuestos antibacterianos.
MX2019011530A (es) Saxitoxinas 11,13-modificadas para el tratamiento del dolor.
EP2493464A4 (en) METHYLSULFONYLMETHANE (MSM) FOR THE TREATMENT OF DRUG-RESISTANT MICROORGANISMS
CR20220082A (es) N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos
MX2022001004A (es) Inhibidores de enzimas.
MX2020011817A (es) Metodos para tratar el linfoma.
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
AU2020231934A8 (en) Compounds useful in HIV therapy
MX2022000811A (es) Inhibidores de enzimas.
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
MX2022003816A (es) Compuestos antibacterianos.
MX2022003814A (es) Compuestos antibacterianos de 4-quinolinona.
MX2022010093A (es) Tafoxiparina para el tratamiento de la preeclampsia.
MX2023010947A (es) Compuestos antibacterianos.
EP4344749A3 (en) Protease formulation for treatment of microbial infections
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
WO2019055748A8 (en) Hydrogen-containing composition
PH12015501428A1 (en) Antibacterial compounds
MX2021004819A (es) Composiciones y metodos para tratar lesiones cerebrales.
MX2020001808A (es) Nuevos compuestos.